April 9, 2009 - According to research presented last week at ACC, patients with the CYP2C19*2 genotype had more ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
April 8, 2009 - The CUPID clinical trial demonstrated acceptable safety and produced quantitative evidence of ...
April 7, 2009 - Lantheus Medical Imaging Inc. has acquired the U.S., Canadian and Australian rights to MS-325 ...
April 2, 2009 - New findings from a landmark investigational study demonstrated that, for patients with atrial ...
April 1, 2009 - On March 30, the Heart Hospital of Austin, TX became the first hospital in the world to treat a ...
March 30, 2009 - The FDA and Watson Pharmaceuticals notified healthcare professionals and patients of a recall of ...
March 30, 2009 - New analysis from the JUPITER study presented at the ACC in Orlando, FL shows that CRESTOR ...
March 24, 2009 - Efficacy and safety study results for Corthera's investigational drug relaxin for the ...
March 20, 2009 - ARCA biopharma Inc., a biopharmaceutical company developing genetically targeted therapies for ...
March 19, 2009 - The Drug Information Association (DIA), in cooperation with the Heart Rhythm Society (HRS) and ...
March 19, 2009 - Sanofi-aventis said yesterday the FDA’s Cardiovascular and Renal Drugs Advisory Committee voted ...
March 18, 2009 - The U.S. Preventive Services Task Force (USPSTF) found that regular aspirin use reduces first ...
March 17, 2009 - Clinical pharmacology company Cetero Research and centralized cardiac testing company Cardiocore ...
March 9, 2009 – Merck & Co. Inc. and Schering-Plough Corp. today said their Boards of Directors unanimously ...
March 5, 2009 - Bristol-Myers Squibb Company yesterday said it is collaborating with Nissan Chemical Industries ...